According to the Institute of Medicine, chronic pain affects more than 100 million Americans, an incidence rate which outpaces heart disease, cancer and diabetes combined. Neuropathic pain represents ...

CARLSBAD, Calif., January 23, 2026--(BUSINESS WIRE)--The 24-month results of the COMFORT Peripheral Nerve Stimulation (PNS) RCT were published on January 23, 2026 in the peer-reviewed journal Chronic ...

This independently analyzed real-world study conducted by research firm OM1 evaluated medical claims data in a comprehensive database of more than 340 million patient lives (OM1’s Real-World Data ...

Please provide your email address to receive an email when new articles are posted on . The FDA has cleared an investigational new drug application for an epigenetic regulator to treat intractable ...

On his good nights, John, a Colorado retiree, dreamed of playing golf again. On bad ones, simply brushing his feet against cotton sheets triggered sleepless agony. He suffered from acute diabetic ...

The idea of using cannabis as medicine is becoming ever more popular. And as states like Minnesota widen access by legalizing recreational — not just medicinal — use of the drug, many people are ...

How Medtronic spinal cord stimulation therapy helped one woman reclaim her life. For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her ...

Published in Pain and Therapy, “Durable Shoulder Pain Relief and Avoidance of Surgery Up To 5 Years Following 60-Day PNS Treatment” evaluates the long-term outcomes and sustained durability following ...

85% of the Active Arm and Crossover Arm were classified as responders (≥50% pain reduction) with an average pain reduction of 67%, consistent with previously published data. 28% were high responders ...